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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYIt has been suggested that the transcription factor Nanog is essential for the establishment of pluripotency during the derivation of
embryonic stem cells and induced pluripotent stem cells (iPSCs). However, successful reprogramming to pluripotency with a growing
list of divergent transcription factors, at ever-increasing efficiencies, suggests that there may be many distinct routes to a pluripotent
state. Here, we have investigated whether Nanog is necessary for reprogramming murine fibroblasts under highly efficient conditions
using the canonical-reprogramming factors Oct4, Sox2, Klf4, and cMyc. In agreement with prior results, the efficiency of reprogramming
Nanog/ fibroblasts was significantly lower than that of control fibroblasts. However, in contrast to previous findings, we were able to
reproducibly generate iPSCs fromNanog/fibroblasts that effectively contributed to the germline of chimericmice. Thus, whereasNanog
may be an important mediator of reprogramming, it is not required for establishing pluripotency in the mouse, even under standard
conditions.INTRODUCTION
The transcription factor Nanog was identified based on its
ability to support embryonic stem cell (ESC) self-renewal
in the absence of leukemia inhibitory factor (LIF) (Cham-
bers et al., 2003). Further studies demonstrated that
Nanog helps to maintain pluripotency in ESCs by pro-
moting Oct4 and Sox2 expression, while inhibiting a
gene expression program leading to primitive endoderm
differentiation (Niakan et al., 2010). Nanog levels have
been shown to fluctuate greatly within ESC cultures
(Chambers et al., 2007; Mitsui et al., 2003). It has been
proposed that allelic regulation of the Nanog gene could
contribute to its heterogeneous expression pattern (Mit-
sui et al., 2003; Chambers et al., 2007; Singh et al.,
2007; Kalmar et al., 2009; MacArthur et al., 2012; Miya-
nari and Torres-Padilla, 2012). However, more recent
single-cell studies using single-molecule mRNA fluores-
cence in situ hybridization or allelic reporters suggest
that allelic regulation of Nanog may not strongly
contribute to variable Nanog expression (Faddah et al.,
2013; Filipczyk et al., 2013).
Although the mechanisms that regulate the expression
of Nanog continue to be intensively studied, it has been
shown that both alleles of Nanog can be eliminated in
ESCswithout interferingwith their differentiation capacity
or somatic engraftment in chimeric animals after blasto-
cyst injection (Chambers et al., 2007). Thus, although
Nanogmay help to maintain pluripotency, it is not strictly
required.Stem CellSubsequent reports argued that although Nanog is not
essential for ESC maintenance, it is absolutely necessary
for the establishment of new ESC lines from blastocyst-
stage embryos (Silva et al., 2009). Similarly, it was found
that induced pluripotent stem cell (iPSC) lines could not
be derived from Nanog/ somatic cells (Silva et al.,
2009). These observations led to the conclusion that
Nanog is an essential ‘‘gate keeper,’’ which must be ex-
pressed before a cell can transit to a pluripotent ‘‘ground
state.’’
Given the important role ofNanog in themaintenance of
pluripotency, it is perhaps surprising that addition ofNanog
to iPSC-reprogramming cocktails does not necessarily
increase the efficiency of reprogramming (Zhao et al.,
2008). Moreover, it has been shown that several distinct
combinations of transcription factors can reprogram fibro-
blasts into iPSCs (Buganim et al., 2012) and that the Nanog
target gene Esrrb can compensate for Nanog deficiency in
some contexts (Festuccia et al., 2012; Martello et al.,
2012). Finally, single-cell analysis of the reprogramming
process suggests that it occurs through a stochastic series
of events in which transcription factor binding and down-
stream transcriptional cascades can occur at random (Buga-
nim et al., 2012; Polo et al., 2012). Consistent with the
mounting evidence that there aremany independent path-
ways to pluripotency, we report here that although elimi-
nating Nanog decreases the efficiency of reprogramming,
Nanog is not required for the generation of iPSCs, even
under canonical conditions utilizing the expression of
Klf4, Sox2, Oct4, and cMyc (KSOM).Reports j Vol. 2 j 119–126 j February 11, 2014 j ª2014 The Authors 119
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We previously found that greatly increasing the titer and
promoter strength of retroviral elements encoding reprog-
ramming factors can dramatically improve the efficiency of
iPSC generation (Dimos et al., 2008; Ichida et al., 2009).We
reasoned that the relatively high efficiency enabled by
these modifications might provide a larger window of
opportunity than that available in earlier experiments
(Silva et al., 2009) for determining whetherNanogwas truly
necessary for the establishment of pluripotency.
In order to test this hypothesis, we first derived Nanog/
somatic cells to use as a target population for reprogram-
ming experiments. We utilized Nanog/ ESCs engineered
to express GFP under the control of the ubiquitously ex-
pressed CAGGS promoter through random integration of
the CAGGS::GFP transgene. These cells were injected into
embryonic day 3.5 (E3.5) blastocysts, transfered into recip-
ient females, and resulting embryos were allowed to
develop to E1.5 (Chambers et al., 2007). We then prepared
mouse embryonic fibroblasts (MEFs) from the resulting
chimeric embryos and purified Nanog/ MEFs via FACS
based on their expression of GFP (Figure S1 available
online).
As a component of the gene-targeting strategy used to
deleteNanog, a neomycin-resistance gene was placed under
control of its endogenous promoter (Chambers et al.,
2007). Thus, selection with the neomycin analog G418
could be used to rule out the unlikely possibility that undif-
ferentiated pluripotent cells, capable of activating the
Nanog promoter, were present in our Nanog/ MEF cul-
tures. We found that no cells in our MEF preparations sur-
vived G418 selection. Thus, there were no undifferentiated
cells remaining in these MEF cultures, and we concluded
that they were an appropriate substrate for determining
whether Nanog was indeed required for the establishment
of pluripotency (Figure 1D, top panel).
To ask whether Nanog/ MEFs could be reprogrammed,
we transduced them with high-titer retroviruses encoding
either Klf4, Sox2, andOct4 (KSO) or KSOM (Figure S1). After
21 days, we reproducibly observed an average of five
colonies with an iPSC morphology per 180,000 Nanog/
MEFs transduced with KSOM, representing a reprogram-
ming efficiency 100-fold lower than obtained using control
Nanog+/+ MEFs (Figures 1A, 1B, and S2B). The oncogene
c-Myc is dispensable for reprogramming, and iPSCs gener-
ated in its absence are less tumorigenic in vivo. We there-
fore next sought to reprogram Nanog/ MEFs using only
KSO. We reproducibly observed two to three putative
iPSC colonies emerge per 180,000 MEFS using these three
factors. Although the efficiency of apparent reprogram-
ming was lower without c-Myc, we were able to generate
iPSC lines using either KSO or KSOM (Figure 1A).120 Stem Cell Reports j Vol. 2 j 119–126 j February 11, 2014 j ª2014 The ATo test whether these Nanog/ cells were indeed reprog-
rammed, we isolated GFP+, putative iPSC colonies and
expanded them in 2i media (Silva et al., 2008). We desig-
nated two putative KSOM Nanog/ iPSC lines, G2 and
G5, whereas two KSO iPSC lines were dubbed 3.1 and
3.2 (Figure 1C). These putative iPSCs maintained an ESC-
like morphology over more than ten passages on both
gelatin and irradiated feeders (Figure 1C). Like Nanog/
ESCs, they grow more slowly than control Nanog+/+ ESCs
(Figure 1C).
Consistent with the notion that these putative Nanog/
iPSCs had been fully reprogrammed to ground state
pluripotency, we found that they had silenced viral reprog-
ramming transgenes and induced endogenous KSO expres-
sion (Figures S2 and 2A). EndogenousOct4was expressed in
these putative Nanog/ iPSCs at levels similar to both con-
trolNanog+/+ ESCs and iPSCs as well as Nanog/ ESCs. Sox2
and Klf4 were expressed in putative Nanog/ iPSCs at
levels similar toNanog/ ESCs but slightly lower than con-
trol Nanog+/+ ESCs and iPSCs (Figure 2A).
To ask if the endogenous pluripotency network was
activated in these putative Nanog/ iPSCs, we performed
drug selection with G418. As mentioned above, because
Nanog/ cells express the neomycin-resistance gene under
control of theNanog promoter, G418 can be used as a proxy
for Nanog promoter activity (Chambers et al., 2007). After
4 days of G418 treatment, putative Nanog/ iPSC lines
G2 and G5 grew without disturbance, whereas control
V6.5 ESCs were drug sensitive (Figure 1D).
We next proceeded to further characterize gene expres-
sion in putative Nanog/ iPSCs. As expected, putative
Nanog/ iPSCs did not express exon 2–4 of theNanog tran-
script, consistent with the gene-targeting strategy used to
generate the knockout line (Chambers et al., 2007).
Conversely, high expression of Nanog was detected in con-
trol Nanog+/+ ESCs and iPSCs, but not in partially reprog-
rammed iPSCs (piPS B1) (Figures 2B and S3). Convergent
expression of Utf1, Dppa2, Lin28, and Esrrb has been
demonstrated to be a stringent indicator of the pluripo-
tent state (Buganim et al., 2012). Thus, we measured
expression of Utf1, Lin28, and Esrrb in putative Nanog/
iPSC lines G2 and G5 and found that they were expressed
at levels similar to those found in Nanog/ ESCs and
control Nanog+/+ V6.5 ESCs. On the other hand, a partially
reprogrammed Nanog+/+ cell line (piPS B1), which is
composed of cells that are not pluripotent, did not express
these genes (Figure 2B).
Having confirmed that theNanog/ iPSCs expressed key
markers of pluripotency, we sought to determine the extent
to which the global expression profile of Nanog/ iPSCs
recapitulated that of ESCs. To this end, we performed
RNA sequencing (RNA-seq) of two replicates each of con-
trolNanog+/+ ESC, iPSC, MEFs, and partially reprogrammeduthors
Figure 1. Nanog Null MEFs Are Reprogrammed Using KSOM and Activate the Pluripotency Transcriptional Network
(A) The number of iPSC colonies generated from Nanog/MEFs with four factors (KSOM) or three factors (KSO). Colonies were scored at day
21 post transduction with reprogramming factors. Error bars represent the SD between two biological replicates.
(B) Primary Nanog/ iPSC colony 17 days post transduction with KSOM. Scale bars represent 500 mm.
(C) Nanog/ iPSCs growing on gelatin (top panels) or on irradiated feeder cells (bottom panels). Scale bars represent 500 mm.
(D) Nanog/ iPSCs activate the endogenous Nanog locus. Cells were treated with 400 ng/ml G418 for 4 days, and representative images
were taken at days 0 and 4. Scale bars represent 500 mm.
See also Figure S1.
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G5. We observed RNA-seq reads aligning to Nanog exon1,
but not exons 2–4, in both the Nanog/ ESC and iPSC
clones (Figure S3). This confirms the absence of Nanog
expression and indicates that the endogenous Nanog pro-
moter is activated in these cells. As expected, we observed
many RNA-seq reads mapping to all exons in control
Nanog+/+ ESCs and iPSCs, but not in control MEFs or
partially reprogrammed iPSCs (Figure S3).
Unsupervised hierarchical clustering of the samples
based on the expression of all genes revealed that all plurip-Stem Cellotent cells clustered together and apart from both MEFs
and partially reprogrammed iPSCs. As expected, both
Nanog/ iPSC lines showed a high degree of similarity to
Nanog/ ESCs (Figure 3A). Pairwise comparisons further
revealed that relative to MEFs, Nanog/ iPSCs were as
similar to Nanog/ ESCs as control, Nanog+/+ iPSCs were
to control Nanog+/+ ESCs (Figure 3C).
Analysis of a wide range of reported pluripotency
markers revealed thatNanog/ iPSCs expressed all markers
with a high degree of similarity to both Nanog/ ESCs and
control ESCs and iPSCs (Figure 3B). Moreover, Nanog/Reports j Vol. 2 j 119–126 j February 11, 2014 j ª2014 The Authors 121
Figure 2. Nanog Null iPSCs Express
Endogenous Pluripotency Genes
(A) qPCR for expression of endogenous KSO.
Levels are normalized to GAPDH and plotted
relative to control V6.5 mESCs (=1). y axis
shows the fold change in expression as
determined by the comparative CT method.
qPCR was performed in duplicate. Error bars
represent the SD between two biological
replicates.
(B) qPCR for expression of pluripotency-
related genes. Levels are normalized to
GAPDH and plotted relative to control V6.5
mESCs (=1). y axis shows the fold change in
expression as determined by the compara-
tive CT method. qPCR was performed in
duplicate. Error bars represent the SD
between two biological replicates.
See also Figure S2.
Stem Cell Reports
Nanog-Independent Reprogramming to iPSCsiPSCs expressed low levels of ectoderm, mesoderm, and
fibroblast markers similar to Nanog/ ESCs. Interestingly,
as previously reported in Nanog/ ESCs (Chambers et al.,
2007, Niakan et al., 2010), each of the Nanog/ iPSC lines
expressed increased levels of early endoderm markers
including Sox17, Gata4, and Gata6 when compared to
Nanog+/+ ESCs or Nanog+/+ iPSCs.
Finally, to definitively test whether these putative
Nanog/ iPSCs were indeed pluripotent, we asked
whether they could colonize chimeric embryos and
contribute differentiated progeny to the three embryonic
germ layers. We injected cells from putative Nanog/
iPSC lines G5, 3.1, and 3.2 into blastocysts and found
that they contributed to E12.5 embryos by green fluores-
cence and to resulting chimeric adults by green fluores-
cence and coat color (Figures 4A–4C). In the case of the
Nanog/ iPSC lines reprogrammed with KSO, 12 out of
16 and 3 out of 8 embryos recovered were chimeric, and
for the Nanog/ iPSC line made with KSOM (G5), 3 out
of 14 embryos were chimeric. Coat-color analysis of adult
mice revealed that for the KSO Nanog/ iPSC lines, 8 out
of 15 and 8 out of 14 animals were chimeric, and for the
KSOM Nanog/, 3 out of 14 animals were chimeric.
Importantly, Nanog/ cells contributed substantially to122 Stem Cell Reports j Vol. 2 j 119–126 j February 11, 2014 j ª2014 The Atissues from the three germ layers in adult chimeras,
including the brain, heart, lung, and liver (Figures 4A
and S4A).
To evaluate if the Nanog/ iPSCs could contribute to the
germline and generate mature germ cells, we crossed
chimeric Nanog/ GFP+ iPSC males with C57BL/6 fe-
males. Genotyping for the GFP transgene in the resulting
adult progeny revealed 7 out of 22 positive animals (Fig-
ure 4E). The genotyping strategy was further confirmed
by detection of GFP expression in the tissues of trans-
gene-positive animals, for example, F1 #4, but not their
transgene-negative littermates (F1 #3, Figure 4F). Partially
reprogrammed cells (piPS B1), on the other hand, did not
contribute to embryonic or adult chimeras (Figure 4D).
These experiments confirmed that unlike the partially re-
programmed Nanog/ cell lines previously derived (Silva
et al., 2009), the Nanog/ iPSC lines we report here were
pluripotent and fully reprogrammed.DISCUSSION
Although our results seem to contradict previous reports
(Silva et al., 2009), we believe that these incongruencesuthors
Figure 3. Nanog Null iPSCs Recapitulate
the Global Transcriptome Profile of ESCs
(A) Unsupervised hierarchical clustering of
global gene expression obtained by RNA-
seq. Biological replicates were analyzed for
each sample, and the composite result is
shown. piPSC, partially reprogrammed iPSC
line B1. JS, Jenson Shannon.
(B) The expression of selected pluripo-
tency-associated factors, as well as early
lineage and fibroblast markers, is shown.
FPKM, fragments per kilobase of transcript
per million fragments mapped. In the case
of Oct4 (Pou5f1) and Sox2, RNA-seq does
not distinguish between endogenous and
exogenous viral transcripts.
(C) The overlap of genes significantly
altered (FDR <0.05) more than 2-fold
between indicated pluripotent stem cells
and MEFs is shown. Genes altered in either
independent Nanog/ iPSC clone (G2
or G5) are included in the Nanog/ iPSC
category.
See also Figure S3.
Stem Cell Reports
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ming in our hands, which allowed us to observe relatively
rare Nanog-independent reprogramming events that were
previously undetected. Regardless, our findings underscore
the redundant and pliable nature of reprogramming
in vitro, further confirming that there are distinct routes
to a pluripotent state. One the one hand, this is not surpris-
ing in light of recent studies showing that redundant fac-
tors within the pluripotency transcriptional network can
compensate for loss of Nanog, and lineage-specific tran-
scription factors can replace all canonical reprogramming
factors when expressed in the right combinations (Festuc-
cia et al., 2012; Martello et al., 2012; Shu et al., 2013). On
the other hand, recent reports that Nanog expression
within pluripotent stem cell cultures is not as heteroge-
neous as previously believed make the finding that it is
not required for transition to or maintenance in the plurip-
otent state surprising (Faddah et al., 2013; Filipczyk et al.,
2013).
Similar to our observation thatNanog/ iPSCs could give
rise to chimeric animals,Nanog null ESCs have been shown
to contribute to the three germ layers (Chambers et al.,
2007). However, in the case of ESC chimeras, Nanog/
GFP+ cells were not detected in the germline after E12.5.
Because the CAGs::GFP construct thatmarksNanog/ cells
was introduced by random integration into ESCs, weStem Cellreasoned that perhaps theGFP transgenemight, by chance,
not be expressed in cells of the germline that could hamper
the ability to detect germline contribution of these cells.
We therefore performed crosses using chimeras produced
from Nanog null iPSCs and found that they could produce
offspring carrying the GFP+ transgene originating from the
injected iPSCs. Thus, these results indicate, in contrast to
previous results, that Nanog/ iPSCs can give rise to func-
tional, mature germ cells.
Here, we provide global transcriptional analysis of both
our Nanog/ iPSCs as well as Nanog/ mESCs (Figure 3).
Although these cells have been shown to robustly colonize
chimeric embryos, we show that there are still many differ-
ences in global expression profiles betweenNanog-deficient
and wild-type (WT) pluripotent stem cells (Figure 3)
(Chambers et al., 2007). A number of genes are differen-
tially expressed between pluripotent cells of these two
genotypes, and thus, it would be interesting to further
investigate both the mechanism of activation of the core
pluripotency network as well as the transcriptional circuit
involved in pluripotency maintenance in this context.
Although we have done this work exclusively in murine
cells, interactions between members of the core pluripo-
tency network are highly conserved between mouse and
human. While the relative inefficiency of iPSC reprogram-
ming in human cellsmaymake rare reprogramming eventsReports j Vol. 2 j 119–126 j February 11, 2014 j ª2014 The Authors 123
Figure 4. Nanog Null iPSCs Are Pluripotent and Extensively Contribute to Chimeras
(A) Representative images of brain, heart, lung, and liver from postnatal day 33 (P33) Nanog/ chimeras generated from injection of
Nanog/ iPSC line 3.1 into WT blastocysts. Scale bars represent 5 mm.
(B) Representative E12.5 chimeras generated from injection of Nanog/ iPSC line 3.1 into WT blastocysts. Scale bars represent 2 mm.
(C) Four-week-old chimera generated from injection of Nanog/ iPSC line 3.1 into WT blastocysts.
(D) Summary of chimera generation results from three and four factor lines (3.1, 3.2, G5). Numbers in boxes represent number of chimeras
and number of embryos or animals recovered and total number of injected embryos. ND, not determined in this experiment. F, female.
(E) Genotyping results of adult progeny (P90) from chimeric and C57BL/6 cross to determine germline transmission of Nanog/ iPSCs.
neg, negative control GFP expression (C57BL/6 uncrossed animal).
(F) Representative images of tissues from adult chimera progeny (P90) genotyped as positive (#4) or negative (#3) GFP transgene, as well
as a chimera parent as a positive control. Scale bars represent 2 mm.
See also Figure S4.
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Nanog-Independent Reprogramming to iPSCsdifficult to detect, it is of great interest to perform similar
experiments in human cells. These studies may provide in-
sights between the so-called naive and primed ESC states in
the NANOG-deficient context (Gafni et al., 2013).
Based on our results, we conclude that although reprog-
ramming is indeed less efficient in the absence of Nanog,
Nanog is not required for the establishment of a pluripotent
state, as has been previously suggested. Instead, we
conclude that even under standard conditions, there are
Nanog-independent routes to pluripotency.EXPERIMENTAL PROCEDURES
iPSC Generation
Parental Nanog/ mESCs were obtained from I. Chambers and
were cultured on feeders in 2i plus LIF conditions as previously
described by Chambers et al. (2007) and Silva et al. (2008). To
obtain Nanog/MEFs, Nanog/ mESCs were injected into blasto-
cyst-stage embryos. At E12.5, MEFs were dissected out and sorted
for constitutive GFP expression, indicating Nanog/ genotype
(Chambers et al., 2007). For reprogramming, MEFs were trans-
duced with retroviruses carrying murine KSO, with or without
c-Myc exactly as described by Ichida et al. (2009). On day 20 post-
transduction with reprogramming transgenes, iPSC colonies were
picked and passaged onto feeders and cultured in 2i plus LIF con-
ditions with passaging every 5 days (Silva et al., 2008).Chimera Generation
All procedures involving animal subjects were approved in
advance by the Harvard University Institutional Animal Care
and Use Committee. Chimeras were generated by injection of
Nanog/ iPSCs into E3.5 strain 129 blastocysts. At E12.5, embryos
were dissected, and whole embryos were analyzed for GFP expres-
sion in somatic tissues. Fourteen-day-old pups were dissected to
analyze chimeric contribution in adult tissues by fluorescence.
To analyze the contribution of Nanog/ iPSCs to the germline,
adult male chimera animals were bred with C57BL/6 females,
and resulting pups were genotyped with Jackson Laboratory GFP
primers 50-AGTTCATCTGCACCACCG-30 and 50- TCCTTGAAGAA
GATGGTGCG-30. Three-month-old adult progeny were analyzed
for chimeric contribution to adult tissues.qPCR
qPCR was performed using iScript cDNA Synthesis Kit and SYBR
Green qPCR Supermix (Bio-Rad) according to manufacturers’ in-
structions on a Bio-Rad iQ5. Levels were normalized to GAPDH
expression using the delta-delta CT method and plotted relative
to expression in control V6.5 mESCs. Primer sequences used for
qPCR: Esrrb, forward 50-CACCTGCTAAAAAGCCATTGACT-30,
reverse 50-CAACCCCTAGTAGATTCGAGACGAT-30; GAPDH, for-
ward 50-TTCACCACCATGGAGAAGGC-30, reverse 50-CCCTTTT
GGCTCCACCCT-30; Klf4, forward 50-CTATGCAGGCTGTGGCA
AAACC-30, reverse 50-TTGCGGTAGTGCCTGGTCAGTT-30; Lin28,
forward 50-GAAGAACATGCAGAAGCGAAGA-30, reverse 50-CCG
CAGTTGTAGCACCTGTCT-30; Nanog, forward 50-AAACCAGTGGStem CellTTGAAGACTAGCAA-30, reverse 50-GGTGCTGAGCCCTTCTGAA
TC-30; Utf1, forward 50-GTCCCTCTCCGCGTTAGC-30, reverse
50-GGCAGGTTCGTCATTTTCC-30; Sox2, forward 50-AAGGGTTC
TTGCTGGGTTTT-30, reverse 50-AGACCACGAAAACGGTCTTG-30;
Oct4, forward 50-CACGAGTGGAAAGCAACTCA-30, reverse 50-AG
ATGGTGGTCTGGCTGAAC-30.
RNA-Seq
RNA was harvested from at least two biological replicates using
TRIzol (Invitrogen) according to the manufacturers’ directions.
RNA quality was determined using BioAnalyzer (Aligent). RNA
integrity numbers above 7.5 were deemed sufficiently high quality
to proceedwith library preparation. In brief, RNA-seq librarieswere
generated from250 ng total RNA using the Illumina TruSeq RNA
kit v.2, according to the manufacturers’ directions. Libraries were
sequenced at the Broad Institute’s Genomics Platform on a HiSeq
2500. A total of 20–60 million 100 bp, paired end reads were
obtained for each sample. Reference files of the murine genome
build mm10, as well as Ensembl transcript annotations, were ob-
tained from iGenomes (http://support.illumina.com/sequencing/
sequencing_software/igenome.ilmn). Reads were aligned to the
genome using the split read aligner TopHat (v.2.0.7) and Bowtie2
(v.2.0.5) using default parameters as previously described by Trap-
nell et al. (2012). Transcript assembly, isoform-specific quantita-
tion and differential expression analysis was performed using
Cufflinks (v.2.1.1) (Trapnell et al., 2012). A genome-wide corrected
false discovery rate (FDR) of less than 0.05 was considered signifi-
cant. Computations were performed on the Odyssey cluster sup-
ported by the FAS Science Division Research Computing Group
at Harvard University.
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